Riskpilot← Back to searchSign inGet full accessALTIUSKLINIKKEN AS
ASActiveOrg 997378105Vangsvegen 121, 2318 HamarPhysiotherapy activities · NACE 8695Est. 20115 employees
Revenue 2024
NOK 2,9M
-4% vs 2023
EBITDA margin
1.5%
-68% vs 2023
Equity ratio
71.5%
Financial strength
Net profit 2024
NOK 9K
-92% vs 2023
| Revenue | NOK 2,9M | -4% |
| EBITDA | NOK 44K | -68% |
| Net profit | NOK 9K | -92% |
| Total assets | NOK 749K | -5% |
| Equity | NOK 536K | +2% |
| Employees | 5 | — |
Legal name
ALTIUSKLINIKKEN AS
Org number
997378105
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
23. september 2011
Share capital
NOK 102 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Fysioterapitjenester med hovedvekt på laserbehandling, investering i selskaper og eiendom samt annen økonomisk virksomhet.
Address
Vangsvegen 121, 2318 Hamar
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 168 | 2 596 | 3 209 | 3 015 | 2 907 |
| Staff expenses | −174 | −269 | −363 | −433 | −447 |
| EBITDA | 5 | 59 | 100 | 136 | 44 |
| Depreciation & amort. | −1 | −12 | −18 | −27 | −15 |
| EBIT | 4 | 48 | 81 | 109 | 29 |
| Net financials | 0 | −5 | −4 | −1 | −2 |
| Profit before tax | 4 | 42 | 77 | 107 | 27 |
| Tax | 11 | 7 | 17 | −7 | 18 |
| Net profit | −6 | 35 | 60 | 114 | 9 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 400 | 530 | 727 | 787 | 749 |
| Equity | 317 | 353 | 413 | 527 | 536 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 83 | 177 | 314 | 260 | 213 |
| Total debt | 83 | 177 | 314 | 260 | 213 |
EBITDA margin
1.5%
This company
15.8%
Market median
-91% vs market
20202024
Equity ratio
71.5%
This company
38.2%
Market median
+87% vs market
20202024
Return on equity
1.6%
This company
18.4%
Market median
-91% vs market
20202024
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20202024
Asset turnover
3.88×
This company
1.12×
Market median
+246% vs market
20202024
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NP Chief Executive Officer | Chief Executive Officer | 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33% | 33.33% | 2022 | |
| Company | 33.33% | 33.33% | 2022 | |
| Individual | 13.33% | 13.33% | 2022 | |
| Individual | 10% | 10% | 2022 | |
| Individual | 10% | 10% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ALTIUSKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Petter Engen | Chief Executive Officer | 0 companies |
| Darren Michael Stainsby | Chairman | 0 companies |